• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

Study of biochemical and other parameters in patients treated with remdesivir vs. without the remdesivir in mildmoderate covid 19 patients

    Dr. Bheemesh Vangalapati, Dr. Sudarshan Reddy, Dr. Venkappa S Mantur, Dr. Avula Naveen, Dr. Arun Kumar

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 818-821

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: The ACTT-1 trial showed that the median time to recovery was 10 days in the
remdesivir group compared to 15 days in the placebo group. However, remdesivir failed to
provide a survival benefit. This study puts in an effort to find the difference in biochemical
and other parameters in patients treated with remdesivir vs. without the remdesivir in mildmoderate
covid 19 patients.
Aims and Objectives: To study the biochemical and other parameters in patients treated with
remdesivir vs. without the remdesivir in mild-moderate covid 19 patients.
Materials and Methods: This study was done in the Department of Pharmacology,
Kanachur Institute of Medical Sciences, Mangalore. This study was done from May 2020 to
June 2021. The study was done in 30 patients who were treated with remdesivir and thirty
without.
Results: There is significant difference between the remdesivir used group when compared to
the unused group.
Conclusion: It may be useful in mild to moderate cases.
Keywords:
    Remdesivir COVID-19 biochemical Parameters
  • PDF (367 K)
  • XML
(2022). Study of biochemical and other parameters in patients treated with remdesivir vs. without the remdesivir in mildmoderate covid 19 patients. European Journal of Molecular & Clinical Medicine, 9(2), 818-821.
Dr. Bheemesh Vangalapati, Dr. Sudarshan Reddy, Dr. Venkappa S Mantur, Dr. Avula Naveen, Dr. Arun Kumar. "Study of biochemical and other parameters in patients treated with remdesivir vs. without the remdesivir in mildmoderate covid 19 patients". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 818-821.
(2022). 'Study of biochemical and other parameters in patients treated with remdesivir vs. without the remdesivir in mildmoderate covid 19 patients', European Journal of Molecular & Clinical Medicine, 9(2), pp. 818-821.
Study of biochemical and other parameters in patients treated with remdesivir vs. without the remdesivir in mildmoderate covid 19 patients. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 818-821.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 69
  • PDF Download: 92
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus